These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 31864976)
1. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis. Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976 [TBL] [Abstract][Full Text] [Related]
2. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040 [TBL] [Abstract][Full Text] [Related]
3. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993 [TBL] [Abstract][Full Text] [Related]
4. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers. Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839 [TBL] [Abstract][Full Text] [Related]
11. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902 [TBL] [Abstract][Full Text] [Related]
12. Serial scanning with Minutoli F; Di Bella G; Mazzeo A; Laudicella R; Gentile L; Russo M; Vita G; Baldari S J Nucl Cardiol; 2021 Oct; 28(5):1949-1957. PubMed ID: 31741327 [TBL] [Abstract][Full Text] [Related]
13. Cardiac scintigraphy with de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587 [TBL] [Abstract][Full Text] [Related]
14. Combination of Commonly Examined Parameters Is a Useful Predictor of Positive Marume K; Takashio S; Nishi M; Hirakawa K; Yamamoto M; Hanatani S; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Sakamoto K; Yamamoto E; Kaikita K; Izumiya Y; Yamashita Y; Ando Y; Tsujita K Circ J; 2019 Jul; 83(8):1698-1708. PubMed ID: 31189791 [TBL] [Abstract][Full Text] [Related]
15. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype. de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102 [TBL] [Abstract][Full Text] [Related]
18. Performance of Guo H; Wu S; Xiang X; Wang S; Fang Z; Ye Q; Zou Y; Wang Y; Peng D; Ma X Ann Nucl Med; 2024 Apr; 38(4):288-295. PubMed ID: 38252229 [TBL] [Abstract][Full Text] [Related]
19. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320 [TBL] [Abstract][Full Text] [Related]